[Chronic hepatitis C in HIV-HCV coinfected patients].
Gervais
Anne
A
Fédération d'Hépatogastroentérologie, Hôpital Beaujon, 100, boulevard Général-Leclerc, 92118 Clichy.
D000328:Adult; D000367:Age Factors; D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002648:Child; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000209:etiology; D016031:Liver Transplantation; D008297:Male; D015201:Meta-Analysis as Topic; D010865:Pilot Projects; D015995:Prevalence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine